H-CYTE is headquartered in Tampa, Florida.
H-CYTE disclosed revenue of 2M USD for 2020 and 8M USD for 2019.
H-CYTE has 8 employees.
H-CYTE is a medical products company.
201 E. Kennedy Blvd. #700,
Tampa, Florida
33602
United States,
(844) 633-6839
www.hcyte.com
H-CYTE was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company's first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | - | - | 2 | - | - | - | 2 |
| Sell (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| 3 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
